Susquehanna International Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.3M | Buy |
|
|||||
|
2025
Q1 | $2.39M | Buy |
|
|||||
|
2024
Q4 | $816K | Sell |
|
|||||
|
2024
Q3 | $1.74M | Buy |
|
|||||
|
2024
Q2 | $1.01M | Sell |
|
|||||
|
2024
Q1 | $1.1M | Sell |
|
|||||
|
2023
Q4 | $1.09M | Buy |
|
|||||
|
2023
Q3 | $674K | Buy |
|
|||||
|
2023
Q2 | $497K | Sell |
|
|||||
|
2023
Q1 | $523K | Sell |
|
|||||
|
2022
Q4 | $856K | Sell |
|
|||||
|
2022
Q3 | $1.35M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.4M | Sell |
|
|||||
|
2021
Q4 | $2.15M | Buy |
|
|||||
|
2021
Q3 | $1.66M | Sell |
|
|||||
|
2021
Q2 | $5.98M | Buy |
|
|||||
|
2021
Q1 | $321K | Sell |
|
|||||
|
2020
Q4 | $5.55M | Buy |
|
|||||
|
2020
Q3 | $369K | Sell |
|
|||||
|
2020
Q2 | $489K | Sell |
|
|||||
|
2020
Q1 | $1.06M | Buy |
|
|||||
|
2019
Q4 | $694K | Sell |
|
|||||
|
2019
Q3 | $2.13M | Sell |
|
|||||
|
2019
Q2 | $11.9M | Buy |
|
|||||
|
2019
Q1 | $1.06M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $1.1M | Sell |
|
|||||
|
2018
Q2 | $13.5M | Buy |
|
|||||
|
2018
Q1 | $6.75M | Buy |
|
|||||
|
2017
Q4 | – | Hold |
|
|||||
|
2017
Q3 | – | Hold |
|
|||||
|
2017
Q2 | – | Hold |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $4.2M | Buy |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Hold |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $549K | Sell |
|
|||||
|
2015
Q3 | $1.18M | Sell |
|
|||||
|
2015
Q2 | $3.18M | Buy |
|
|||||
|
2015
Q1 | $718K | Buy |
|
|||||
|
2014
Q4 | $448K | Sell |
|
|||||
|
2014
Q3 | $584K | Sell |
|
|||||
|
2014
Q2 | $1.61M | Buy |
|
|||||
|
2014
Q1 | $679K | Sell |
|
|||||
|
2013
Q4 | $536K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $276K | Buy |
|